Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Protagonist Therapeutics (PTGX) Return on Sales: 2018-2025

Historic Return on Sales for Protagonist Therapeutics (PTGX) over the last 6 years, with Sep 2025 value amounting to 0.23%.

  • Protagonist Therapeutics' Return on Sales fell 32.00% to 0.23% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.23%, marking a year-over-year decrease of 32.00%. This contributed to the annual value of 0.63% for FY2024, which is 195.00% up from last year.
  • Protagonist Therapeutics' Return on Sales amounted to 0.23% in Q3 2025, which was down 11.80% from 0.26% recorded in Q2 2025.
  • Protagonist Therapeutics' Return on Sales' 5-year high stood at 0.64% during Q4 2024, with a 5-year trough of -4.66% in Q3 2021.
  • Its 3-year average for Return on Sales is 0.25%, with a median of 0.40% in 2025.
  • Examining YoY changes over the last 5 years, Protagonist Therapeutics' Return on Sales showed a top increase of 1,799bps in 2021 and a maximum decrease of 64bps in 2021.
  • Over the past 5 years, Protagonist Therapeutics' Return on Sales (Quarterly) stood at -4.60% in 2021, then surged by 98bps to -3.61% in 2022, then surged by 258bps to -1.03% in 2023, then surged by 167bps to 0.64% in 2024, then crashed by 32bps to 0.23% in 2025.
  • Its Return on Sales was 0.23% in Q3 2025, compared to 0.26% in Q2 2025 and 0.28% in Q1 2025.